RG

Ruturaj Govindbhai Mori

Active Director Designated Partner DIN 11474279
DIN 11474279 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ruturaj Govindbhai Mori

Data last updated:

Ruturaj Govindbhai Mori is a Designated Partner at Shivshakti Pharma Chem Llp (since 2026).

DIN 11474279
Primary Designation Designated Partner
First Appointment 09 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Jan 20262026Active

Board colleagues of Ruturaj Govindbhai Mori

NameDINCompanyDesignation
Princeraj Vikrambhai Mori11474281Shivshakti Pharma Chem LlpDesignated Partner
Yuvrajsinh Virambhai Mori11474280Shivshakti Pharma Chem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Shivshakti Pharma Chem Llp
Premium access

Shareholding and investment profile for Ruturaj Govindbhai Mori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruturaj Govindbhai Mori

Ruturaj Govindbhai Mori currently holds 1 directorship: Shivshakti Pharma Chem Llp (Designated Partner, since 09 Jan 2026).

Ruturaj Govindbhai Mori was first appointed on 09 Jan 2026 as Designated Partner at Shivshakti Pharma Chem Llp.

The current boards of Ruturaj Govindbhai Mori's companies include Princeraj Vikrambhai Mori (Shivshakti Pharma Chem Llp), Yuvrajsinh Virambhai Mori (Shivshakti Pharma Chem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available